Literature DB >> 372241

Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas.

M Otsuki, C Sakamoto, H Yuu, M Maeda, S Morita, A Ohki, N Kobayashi, K Terashi, K Okano, S Baba.   

Abstract

The effects of highly purified natural porcine cholecystokinin (CCK) and synthetic caerulein on the rate of flow of pancreatic juice, the rate of output of amylase, and the rate of release of immunoreactive insulin (IRI) and immunoreactive glucagon (IRG) were simultaneously investigated in the isolated perfused rat pancreas. The maximal flow rate of pancreatic juice was obtained with concentrations of CCK ranging from 0.5 to 10 mU/ml, whereas amylase output was maximal at CCK concentrations from 1 to 10 mU/ml. Caerulein at concentrations of 0.05-1 ng/ml induced a similar maximal flow rate and amylase secretion. Supramaximal stimulatory concentrations of these peptides resulted in lower rates of release of fluid and amylase than with the maximally effective concentrations. Stimulation of IRI and IRG release was elicited only with concentrations of peptides supramaximal for effects on the exocrine responses. The demonstration of very similar discrepancies between the doses of caerulein required to elicit maximal exocrine responses and those required to elicit endocrine responses provide strong evidence that the pattern of the effect of the porcine CCK is accounted for by CCK itself. Although caerulein had no influence on IRI response when superimposed on 100 or 150 mg/100 ml glucose stimulation, preperfusion of caerulein led to a significant enhancement of IRI response to a subsequent glucose stimulation in both phases. The augmentation effect was completely separate from the direct IRI-stimulating effect of caerulein, because the CCK-like peptide requires no glucose for insulinotropic action. Because the concentrations of the peptides necessary for stimulation of endocrine responses were inhibitory in their effects on exocrine responses, it may be inferred that it is unlikely that the endocrine effect is physiologically important, though the results of caerulein for augmenting glucose-stimulated IRI release suggests a possible role for CCK in carbohydrate metabolism.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 372241      PMCID: PMC371976          DOI: 10.1172/JCI109325

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Assay of Jorpes-Mutt secretin and cholecystokinin.

Authors:  A C IVY; H M JANECEK
Journal:  Acta Physiol Scand       Date:  1959-03-31

2.  Pancreozymin, a stimulant of the secretion of pancreatic enzymes in extracts of the small intestine.

Authors:  A A Harper; H S Raper
Journal:  J Physiol       Date:  1943-06-30       Impact factor: 5.182

3.  The effects of gastrin, gastric inhibitory polypeptide, secretin, and the octapeptide of cholecystokinin upon immunoreactive somatostatin release by the perfused canine pancreas.

Authors:  E Ipp; R E Dobbs; V Harris; A Arimura; W Vale; R H Unger
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

4.  The augmentation effects of secretin on the insulin responses to known stimuli: specificity for glucose.

Authors:  R L Lerner
Journal:  J Clin Endocrinol Metab       Date:  1977-07       Impact factor: 5.958

5.  Effects of the gastric inhibitory polypeptide present in impure pancreozymin-cholecystokinin on plasma insulin and glucagon in the rat.

Authors:  A Rabinovitch; J Dupré
Journal:  Endocrinology       Date:  1974-04       Impact factor: 4.736

6.  Calcium-dependent amylase release and electrophysiological measurements in cells of the pancreas.

Authors:  T Kanno
Journal:  J Physiol       Date:  1972-10       Impact factor: 5.182

7.  The potentiating influences of insulin on pancreozymin-induced hyperpolarization and amylase release in the pancreatic acinar cell.

Authors:  T Kanno; A Saito
Journal:  J Physiol       Date:  1976-10       Impact factor: 5.182

8.  Effects of secretin, pancreozymin, or gastrin on the response of the endocrine pancreas to administration of glucose or arginine in man.

Authors:  J Dupre; J D Curtis; R H Unger; R W Waddell; J C Beck
Journal:  J Clin Invest       Date:  1969-04       Impact factor: 14.808

9.  Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide.

Authors:  E Ipp; R E Dobbs; A Arimura; W Vale; V Harris; R H Unger
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

10.  The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs.

Authors:  R H Unger; H Ketterer; J Dupré; A M Eisentraut
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

View more
  17 in total

1.  Exocrine pancreatic function in rats after acute trypsin inhibitor treatment.

Authors:  M Otsuki; A Ohki; C Sakamoto; Y Okabayashi; S Baba
Journal:  Dig Dis Sci       Date:  1985-03       Impact factor: 3.199

2.  Inhibitory effects of pirenzepine on cholecystokinin and secretin stimulation on exocrine and endocrine rat pancreas.

Authors:  M Otsuki; Y Okabayashi; T Nakamura; M Fujii; T Oka; S Tani; S Baba
Journal:  Dig Dis Sci       Date:  1987-10       Impact factor: 3.199

3.  Histologic and biochemical alterations in experimental acute pancreatitis induced by supramaximal caerulein stimulation.

Authors:  S Tani; M Otsuki; H Itoh; M Fujii; T Nakamura; T Oka; S Baba
Journal:  Int J Pancreatol       Date:  1987 Oct-Dec

4.  Pancreatic secretory response to cholecystokinin-pancreozymin and caerulein in the conscious rat.

Authors:  R Laugier; A Papp; P Demol; J J Charbit; H Sarles
Journal:  Pflugers Arch       Date:  1980-03       Impact factor: 3.657

5.  Effect of a new cholinergic agonist, aclatonium napadisilate, on exocrine and endocrine rat pancreas.

Authors:  M Otsuki; T Nakamura; Y Okabayashi; M Fujii; S Tani; T Fujisawa; S Baba
Journal:  Dig Dis Sci       Date:  1989-08       Impact factor: 3.199

6.  Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.

Authors:  M Otsuki; M Fujii; T Nakamura; Y Okabayashi; S Tani; T Fujisawa; M Koide; S Baba
Journal:  Dig Dis Sci       Date:  1989-06       Impact factor: 3.199

7.  Exocrine and endocrine secretion from isolated perfused rat pancreas with islet cell tumors induced by streptozotocin and nicotinamide.

Authors:  C Sakamoto; M Otsuki; A Ohki; T Kazumi; T Yamasaki; H Yuu; M Maeda; G Yoshino; S Baba
Journal:  Dig Dis Sci       Date:  1984-05       Impact factor: 3.199

8.  Effect of acarbose on exocrine and endocrine pancreatic function in the rat.

Authors:  M Otsuki; C Sakamoto; A Ohki; Y Okabayashi; I Suehiro; S Baba
Journal:  Diabetologia       Date:  1983-06       Impact factor: 10.122

9.  Effect of diabetes mellitus on pancreatic exocrine secretion from isolated perfused pancreas in rats.

Authors:  Y Okabayashi; M Otsuki; A Ohki; I Suehiro; S Baba
Journal:  Dig Dis Sci       Date:  1988-06       Impact factor: 3.199

10.  The effects of caerulein on exocrine pancreatic secretion in pigs.

Authors:  C Belloli; P Ormas; S Cissokho; C Beretta
Journal:  Vet Res Commun       Date:  1983-01       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.